ArticleScientific reports2025

Exploring Liraglutide's mechanism in reducing renal fibrosis: the Fsp1-CoQ10-NAD(P)H pathway.

Qi Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.